Skip to main content
Premium Trial:

Request an Annual Quote

Everyone Wants to Sequence

With rapid changes to sequencing technology, Dan Koboldt at MassGenomics says that "genomes abound" and that "everyone wants to sequence," though not every lab can afford its own sequencer. Enter sequence service providers such as BGI and Complete Genomics. "These new sequencers and service providers are going to put high-throughput sequencing into the hands of many investigators. Investigators, I might add, who likely have never dealt with NGS data," Koboldt writes. "I think that's potentially very exciting, and I hope that the experiences of major genome centers will help newcomers address the challenges of massively parallel sequencing.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.